21 March 2023 Invitation to Scandion Oncology webcast and conference call March 28, 2023 Download Presentation Webcast Workbook
15 February 2023 Invitation to Scandion Oncology webcast and conference call February 22, 2023 Download Presentation Webcast Workbook
19 January 2023 Scandion Oncology A/S: Scandion Oncology receives favorable opinion from the European Patent Office on Composition of Matter Patent-application for lead compound SCO-101 Download Presentation Webcast Workbook
5 December 2022 Scandion Oncology announces share purchase by incoming President & CEO Download Presentation Webcast Workbook
23 November 2022 Scandion Oncology announces share purchase by member of the Board of Directors Download Presentation Webcast Workbook
10 November 2022 Invitation to Scandion Oncology webcast and conference call November 16, 2022 Download Presentation Webcast Workbook
10 October 2022 Scandion Oncology initiates part 3 of the CORIST phase II trial Download Presentation Webcast Workbook
30 September 2022 Scandion Oncology announce topline results from part 2 of the CORIST phase II trial Download Presentation Webcast Workbook
19 August 2022 Scandion Oncology receives approvals for next parts of the CORIST trial Download Presentation Webcast Workbook
18 August 2022 Invitation to Scandion Oncology webcast and conference call August 25, 2022 Download Presentation Webcast Workbook
17 August 2022 Scandion Oncology extends PANTAX trial due to better-than-expected tolerability of SCO-101 Download Presentation Webcast Workbook
8 August 2022 Scandion Oncology announces share purchase by Board of Directors Download Presentation Webcast Workbook